Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity - Editorial comment

被引：41
作者：
Chancellor, MB [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA 15261 USA
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 02期
关键词：
Bladder; neurogenic; Botulinum toxins; Drug resistance;
D O I：
10.1097/01.ju.0000108407.53880.6a
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：804 / 805
页数：2
相关论文
共 50 条
  • [21] Experience with Different Botulinum Toxins for the Treatment of Refractory Neurogenic Detrusor Overactivity EDITORIAL COMMENT
    Amaro, Joao Luiz
    INTERNATIONAL BRAZ J UROL, 2010, 36 (01): : 73 - 74
  • [22] Clinical outcomes of botulinum toxin A management for neurogenic detrusor overactivity: meta-analysis
    Wu, Shang-Jun
    Xu, Yu-Qiong
    Gao, Zheng-Yan
    Wang, Zhi-Peng
    Zhao, Feng
    Liu, Lin
    Wang, Sheng
    RENAL FAILURE, 2019, 41 (01) : 937 - 945
  • [23] Efficacy of Botulinum Toxin A Injection for Neurogenic Detrusor Overactivity and Urinary Incontinence: A Randomized, Double-Blind Trial
    Herschorn, Sender
    Gajewski, Jerzy
    Ethans, Karen
    Corcos, Jacques
    Carlson, Kevin
    Bailly, Gregory
    Bard, Robert
    Valiquette, Luc
    Baverstock, Richard
    Carr, Lesley
    Radomski, Sidney
    JOURNAL OF UROLOGY, 2011, 185 (06) : 2229 - 2235
  • [24] Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia
    Sekerci, Cagri Akin
    Tanidir, Yiloren
    Toprak, Tuncay
    Basok, Banu Isbilen
    Isman, Ferruh
    Simsek, Ferruh
    Akbal, Cem
    Tarcan, Tufan
    JOURNAL OF UROLOGY, 2019, 201 (01) : 174 - 180
  • [25] Efficacy and Tolerability of Botulinum Toxin Type A in Patients with Neurogenic Detrusor Overactivity and Without Concomitant Anticholinergic Therapy: Comparison of Two Doses
    Grise, Philippe
    Ruffion, Alain
    Denys, Pierre
    Egon, Guy
    Kastler, Emmanuel Chartier
    EUROPEAN UROLOGY, 2010, 58 (05) : 759 - 766
  • [26] Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years
    Stoehrer, Manfred
    Wolff, Andreas
    Kramer, Guus
    Steiner, Rainer
    Loechner-Ernst, Dieter
    Leuth, Dirk
    Steude, Ute
    Ruebben, Herbert
    UROLOGIA INTERNATIONALIS, 2009, 83 (04) : 379 - 385
  • [27] Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: A prospective randomized study
    Giannantoni, A
    Di Stasi, SM
    Stephen, RL
    Bini, V
    Costantini, E
    Porena, M
    JOURNAL OF UROLOGY, 2004, 172 (01) : 240 - 243
  • [28] Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: A retrospective study of seven cases
    Thanh, C. Do Ngoc
    Audry, G.
    Forin, V.
    JOURNAL OF PEDIATRIC UROLOGY, 2009, 5 (06) : 430 - 436
  • [29] Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions
    Klaphajone, J
    Kitisomprayoonkul, W
    Sriplakit, S
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2005, 86 (11): : 2114 - 2118
  • [30] How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity
    Mailho, Camille
    Peyronnet, Benoit
    De Seze, Marianne
    Even, Alexia
    Perrouin-Verbe, Maire-Aimee
    Amarenco, Gerard
    Chartier-Kastler, Emmanuel
    Le Normand, Loic
    Manunta, Andrea
    Karsenty, Gilles
    Kerdraon, Jacques
    Ruffion, Alain
    Saussine, Christian
    Le Breton, Frederique
    Bernuz, Benjamin
    Castel-Lacanal, Evelyne
    Denys, Pierre
    Phe, Veronique
    Game, Xavier
    NEUROUROLOGY AND URODYNAMICS, 2024, : 811 - 817
12345